-
18/11/2008
Aids drugs side effects probed
-
05/11/2008
Aids foundation calls for action from Obama
-
17/11/2008
Aids testing encouraged in India
-
04/11/2008
Asian countries pool data to fight flu
-
13/11/2008
No sign of HIV in transplant patient
-
10/11/2008
Bird flu found in northern Thailand
-
18/11/2008
Calculating malaria drug demand 'crucial'
-
19/11/2008
Call for more animal research
-
05/11/2008
Call for universal vaccine
-
11/11/2008
Chinese herbal therapy used to help fight HIV
-
14/11/2008
Cholera cases triple in DR Congo
-
12/11/2008
Commercial poultry 'more vulnerable' to flu
-
12/11/2008
Drug resistant TB rare in US
-
03/11/2008
Early vaccines 'ward against whooping cough'
-
13/11/2008
Fear of increase in airport malaria in US
-
04/11/2008
Fears over spread of HIV among families
-
19/11/2008
Fines for failing to protect against Dengue
-
03/11/2008
Flu jab works despite irregularities
-
06/11/2008
Food shortages obstruct HIV/Aids treatment
-
11/11/2008
Global Fund approves $2.75bn
-
06/11/2008
Growing resistance to TB meds
-
13/11/2008
Indonesia denies bird flu death
-
06/11/2008
Malawi gets $20m Aids grant
-
17/11/2008
Malaysia bans poultry from Thailand
-
18/11/2008
Meeting malaria targets 'unlikely'
-
14/11/2008
Nasal vaccine for bird flu moves forward
-
19/11/2008
New pill 'reduces Aids risk by two-thirds'
-
05/11/2008
Nigeria opts for in-house drugs
-
17/11/2008
Old British law 'an obstacle' to fight against Aids
-
07/11/2008
Poor bank cooperation stymies international aid
-
10/11/2008
Scientists engineer HIV assassin cells
-
07/11/2008
South Africa aims for 80 per cent treatment rate
-
14/11/2008
South Africa tackles Aids drugs shortages
-
03/11/2008
Study discovers bacterial pathway
-
07/11/2008
Threat of HIV/Aids from rapes in the DR Congo
-
12/11/2008
US donates $44.4m to tackle bird flu
-
04/11/2008
Vietnam on dengue alert after flooding
-
10/11/2008
Zimbabwe bank gives back aid cash
-
11/11/2008
Zimbabwean health system receives funding
HIV tests for US 13-year-olds
A US drugs firm has just received approval to conduct HIV/Aids tests on 13-year-olds.
Increasing the patient focus is in line with US Centers for Disease Control recommendations that 13 to 64-year-olds should be routinely screened for HIV, reported Market Watch.
A study of the different ways Chembio tested resulted in the green light for 13 to 17-year-olds, a recently untapped demographic.
One million people are estimated to be living with HIV in the US with 21 per cent unaware they have the virus.
In 2006, five per cent of people with HIV/Aids were aged 13 to 24 years old.
The governor of California Arnold Schwarzenegger recently made it mandatory for private health insurance companies to cover the cost of HIV tests.
Opt-out testing is now being introduced opposed to risk based to curb the number of people contracting HIV.
Chembio chairman and chief executive Lawrence Siebert said: "This will increase the opportunity for testing and early diagnosis and could subsequently lower infection rates as patients become aware of their HIV status."
News brought to you by Global Health TV, covering the issues of health in the developing world.
Send this article to a friend
Comment on this article
Bookmark this video